Calidi Biotherapeutics
CLDI----
Calidi Biotherapeutics (CLDI)
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers C...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Calidi Biotherapeutics Analyst Rating
View MoreForecast & Rating
Jul 22, 2025Price forecast
$120.00119904.80%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 20 hours ago
Inside the Biotech Sector's Recent Clinical Catalyst Wave
- Global Report · 20 hours ago
Sector Watch: Wix's AI Overhaul and Crypto Pivots in Small-Cap Space
- Global Report · 1 day ago, 04:13 AM
The AI Spillover: How the Market's Edges are Rewiring Real Infrastructure
- Baystreet · Jul 21 at 08:50 AM
Calidi Gains on Company Update
- Unusual Whales · Jul 21 at 07:10 AM
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
- PUBT · Jul 21 at 07:03 AM
Calidi Biotherapeutics adds former Genentech, Celgene executive Corsee Sanders to board
